Imatinib Mesylate Causes Growth Plate Closure in Vivo

Leukemia - United Kingdom
doi 10.1038/leu.2009.150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Imatinib Mesylate Inhibits Fibrogenesis in Asbestos-Induced Interstitial Pneumonia

Experimental Lung Research
Respiratory MedicinePulmonaryClinical BiochemistryMolecular Biology
2007English

Imatinib Mesylate Treatment for Platelet-Derived Growth Factor Receptor Alfa-Positive Choroid Plexus Carcinoma

Clinics and Practice
2012English

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Imatinib Mesylate Associated With Delayed Hematopoietic Recovery After Concomitant Chemotherapy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Phase I Clinical Trial Combining Imatinib Mesylate and IL-2

OncoImmunology
OncologyAllergyImmunology
2013English

Development of Analytical Method for Imatinib Mesylate by Ultraviolet Spectroscopy

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2019English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial

The Lancet Oncology
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy